- Home
- INBX vs BMN Comparison
INBX vs BMN Comparison
Compare INBX & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- BMN
- Stock Information
- Founded
- INBX 2010
- BMN 2020
- Country
- INBX United States
- BMN United States
- Employees
- INBX N/A
- BMN 19800
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- BMN Trusts Except Educational Religious and Charitable
- Sector
- INBX Health Care
- BMN Finance
- Exchange
- INBX Nasdaq
- BMN Nasdaq
- Market Cap
- INBX 178.5M
- BMN 146.9M
- IPO Year
- INBX 2020
- BMN N/A
- Fundamental
- Price
- INBX $12.96
- BMN $25.30
- Analyst Decision
- INBX Hold
- BMN
- Analyst Count
- INBX 1
- BMN 0
- Target Price
- INBX N/A
- BMN N/A
- AVG Volume (30 Days)
- INBX 86.5K
- BMN 29.9K
- Earning Date
- INBX 05-14-2025
- BMN 01-01-0001
- Dividend Yield
- INBX N/A
- BMN 4.66%
- EPS Growth
- INBX N/A
- BMN N/A
- EPS
- INBX 111.58
- BMN N/A
- Revenue
- INBX $200,000.00
- BMN N/A
- Revenue This Year
- INBX N/A
- BMN N/A
- Revenue Next Year
- INBX N/A
- BMN N/A
- P/E Ratio
- INBX $0.12
- BMN N/A
- Revenue Growth
- INBX N/A
- BMN N/A
- 52 Week Low
- INBX $10.80
- BMN $21.51
- 52 Week High
- INBX $18.95
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- INBX 53.35
- BMN 54.94
- Support Level
- INBX $12.72
- BMN $24.03
- Resistance Level
- INBX $13.90
- BMN $24.56
- Average True Range (ATR)
- INBX 0.67
- BMN 0.34
- MACD
- INBX 0.06
- BMN 0.04
- Stochastic Oscillator
- INBX 53.87
- BMN 41.35
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.